News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
|
Followers
|
69
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
9343
|
|
Created
|
10/22/04
|
Type
|
Free
|
| Moderators | |||
May 25, 2011 Registration Revoked by SEC
| SinoFresh HealthCare, Inc. develops products that help people alleviate chronic health problems. The company's mandate is to be a leader in the field of product development for chronic sinus distress as well as providing innovative solutions to upper respiratory problems, a malady that affects more than 37 million Americans. SinoFresh HealthCare was founded in 1999 and leverages a distinguished panel of medical experts and a seasoned management team with broad biopharmaceutical industry experience. The company holds several patents on its innovative pharmaceutical technology. SinoFresh HealthCare catapulted to prominence in 2002 by test marketing its antiseptic nasal spray (SinoFresh™) on the west coast of Florida. SinoFresh focuses on the positive effects that may be achieved with effortless, routine nasal cleansing. SinoFresh HealthCare is headquartered in Venice, FL and manufactures and distributes SinoFresh products globally under an exclusive license granted to Sinofresh Healthcare Products, Inc. |  |
Management Team
| Tom Fitzgerald, Chairman of the Board Mr. Fitzgerald has more than 25 years of experience in the biopharmaceutical industry. As an industry consultant and senior executive, he has provided strategic advice for a range of early stage companies and turnaround candidates as well as working with and for well established domestic and multinational businesses. He has also worked with a number of research based institutions including the University of Rochester, the Scripps Institute and Thomas Jefferson University on the generation and growth of spin out life science business from their intellectual property.
|
| David R. Olund, Chief Executive Officer Mr. Olund has over 30 years of domestic and international experience in the Financial Services and Finance industry. |
| William H. Baumgardner, Chief Financial Officer Mr. Baumgardner is a CPA with 35 years of experience in all aspects of operational and management accounting, finance and fiscal controls with both domestic public and private companies including Fisher Scientific, American Can Co., and various start-up enterprises. |
| Bill Wilferth, Vice President of Research &Development Mr. Wilferth joined SinoFresh HealthCare in January 2003 as VP Quality Assurance. Shortly after joining the company he assumed responsibility for R&D, Operations and later Business Development.Mr. Wilferth came to the company with over 25 years of experience in the Pharmaceutical industry with experience in Quality Assurance, Regulatory Affairs, FDA liaison and Clinical Research. He holds a degree in Pharmacy from the University of Buffalo and a Masters Degree in Statistics from the Rochester Institute of Technology. He is a licensed pharmacist in New York and Florida and has also completed the Certified Lead Assessor training course in ISO 9000 Quality Systems from the British Standards Institute.Mr. Wilferth has been responsible for all research & development efforts since his arrival at the company including product formulation development and in-vitro/in-vivo testing conducted on Methicillin Resistant Staphylococcus Aureus (MRSA) and viruses. |
Press Releases
Gulf Coast Business Review Article - 3/11/2011
| Medical Papers Welcome to our Press area. Here you will find reference material, corporate logos, and product images. General
Reports
|
| Summary Financial Reports Current Management Discussion for Shareholders |
Authorized 5,000,000,000
Outstanding 3,229,764,335
Float 729,764,335
Protect your family from germs and viruses!
Use SinoFresh everyday and be worry free!
Prevention without a Pescription
